Ladonya Jackson-Cowan

190PUBLICATIONS
267CO-AUTHORS
Epidemiological modellingMolecular targetsPredictive and prognostic markersGene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (190)

|Sep 22, 2026
Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial.

|Jul 22, 2026
Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial.

|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

|Apr 28, 2026
Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years.

|Dec 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.

Sonja Ständer, Sarina B Elmariah, Shawn G Kwatra

|Nov 15, 2025
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years.

Christopher G Bunick, Alan D Irvine, Jonathan I Silverberg

Pageof 32

Frequent Collaborators

18 joint publications

Erin M Warshaw

15 joint publications

Emma Guttman-Yassky

14 joint publications

Jacob Pontoppidan Thyssen

12 joint publications

Eric Simpson